ZA200210206B - Expression system. - Google Patents

Expression system.

Info

Publication number
ZA200210206B
ZA200210206B ZA200210206A ZA200210206A ZA200210206B ZA 200210206 B ZA200210206 B ZA 200210206B ZA 200210206 A ZA200210206 A ZA 200210206A ZA 200210206 A ZA200210206 A ZA 200210206A ZA 200210206 B ZA200210206 B ZA 200210206B
Authority
ZA
South Africa
Prior art keywords
expression system
expression
Prior art date
Application number
ZA200210206A
Other languages
English (en)
Inventor
Ethel Diane Williamson
Nicola Jane Walker
Paula Thomson Holden
Helen Lisa Bullifent
Andrew William Topping
Miller Julie Baillie Les James
Helen Claire Flick-Smith
Richard William Titball
Original Assignee
Secr Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Secr Defence filed Critical Secr Defence
Publication of ZA200210206B publication Critical patent/ZA200210206B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200210206A 2000-07-08 2002-12-17 Expression system. ZA200210206B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0016702.3A GB0016702D0 (en) 2000-07-08 2000-07-08 Expression system

Publications (1)

Publication Number Publication Date
ZA200210206B true ZA200210206B (en) 2004-03-17

Family

ID=9895205

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200210206A ZA200210206B (en) 2000-07-08 2002-12-17 Expression system.

Country Status (10)

Country Link
US (3) US7537771B2 (xx)
EP (2) EP1301606A1 (xx)
JP (2) JP2004502460A (xx)
CN (2) CN101012458A (xx)
AU (1) AU2007201553B8 (xx)
CA (2) CA2658217A1 (xx)
GB (1) GB0016702D0 (xx)
RU (2) RU2270865C2 (xx)
WO (1) WO2002004646A1 (xx)
ZA (1) ZA200210206B (xx)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0016702D0 (en) 2000-07-08 2000-08-23 Secr Defence Brit Expression system
US7601351B1 (en) 2002-06-26 2009-10-13 Human Genome Sciences, Inc. Antibodies against protective antigen
AU2003278776A1 (en) * 2002-09-10 2004-04-30 Vical Incorporated Codon-optimized polynucleotide-based vaccines against bacillus anthracis infection
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
EP1572977B1 (en) 2002-11-15 2010-03-03 Gen-Probe Incorporated Assay and compositions for detection of bacillus anthracis nucleic acid
EP1670505B1 (en) 2003-09-18 2012-11-14 GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Dna promoters and anthrax vaccines
FR2860005A1 (fr) * 2003-09-23 2005-03-25 Univ Aix Marseille Ii Methode de detection d'agents bacteriens ou viraux de bioterrorisme
WO2005030991A1 (fr) * 2003-09-23 2005-04-07 Universite De La Mediterranee (Aix-Marseille Ii) Methode de detection d’agents bacteriens ou viraux de bioterrorisme
GB0401036D0 (en) * 2004-01-17 2004-02-18 Royal Holloway University Of L Improvements in or relating to vaccination
US8101735B2 (en) 2004-06-16 2012-01-24 Health Protection Agency Preparation of protective antigen
US7355027B2 (en) * 2004-06-16 2008-04-08 Dynport Vaccine Company Llc Bacillus anthracis protective antigen
AU2005269527B2 (en) 2004-07-26 2011-12-01 Pfenex Inc. Process for improved protein expression by strain engineering
CN100336908C (zh) * 2004-09-10 2007-09-12 中国人民解放军军事医学科学院微生物流行病研究所 一种制备重组炭疽保护性抗原的方法及其专用表达质粒
WO2006068647A1 (en) * 2004-12-20 2006-06-29 United States Army Medical Research And Materiel Command Internal positive control for probe-based nucleic acid molecule assays and methods of making and using thereof
GB0504940D0 (en) * 2005-03-10 2005-04-20 Secr Defence Vaccine formulation
EP1954307A4 (en) 2005-11-14 2009-12-02 Univ Maryland Biotech Inst ORAL VACCINES AGAINST MILZBRAND ON SALMONELLA BASE
GB0525213D0 (en) * 2005-12-12 2006-01-18 Secr Defence Vaccine
CA2634163A1 (en) * 2005-12-22 2007-06-28 Iq Corporation Compositions and methods of modulating the immune response
GB0607462D0 (en) * 2006-04-13 2006-05-24 Avecia Ltd Assay
JP2008231063A (ja) * 2007-03-22 2008-10-02 Takano Foods Kk 納豆菌ワクチン
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
CA2685326A1 (en) 2007-04-27 2008-11-06 Dow Global Technologies Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9616117B2 (en) 2008-10-02 2017-04-11 Pharmathene, Inc. Anthrax vaccine formulation and uses thereof
US20110256172A1 (en) * 2008-10-14 2011-10-20 The Regents Of The University Of Michigan Epitope-targeted anthrax vaccine
US20100183675A1 (en) * 2009-01-22 2010-07-22 Allan Watkinson Stable vaccine compositions and methods of use
US8187611B2 (en) * 2009-10-29 2012-05-29 Albert Einstein College Of Medicine Of Yeshiva University Anti-peptide antibodies that cross react with protective antigen of Bacillus anthracis and uses thereof
US20110110968A1 (en) * 2009-11-12 2011-05-12 Stanley Goldman Human optimized Bacillus anthracis protective antigen
CN101798565B (zh) * 2010-02-26 2013-08-07 中国人民解放军军事医学科学院生物工程研究所 能在芽孢表面展示pa20蛋白的炭疽芽孢杆菌及其应用
RU2633504C1 (ru) * 2016-12-27 2017-10-12 Федеральное государственное учреждение "Федеральный исследовательский центр "Фундаментальные основы биотехнологии" Российской академии наук (ФИЦ Биотехнологии РАН) Штамм E.coli - продуцент полноразмерного протективного антигена Bacillus anthracis в форме вирусоподобных частиц
RU2633508C1 (ru) * 2016-12-27 2017-10-12 Федеральное государственное учреждение "Федеральный исследовательский центр "Фундаментальные основы биотехнологии" Российской академии наук (ФИЦ Биотехнологии РАН) Штамм E. coli - продуцент изолированного домена 1 протективного антигена Bacillus anthracis в форме вирусоподобных частиц
WO2020116686A1 (ko) * 2018-12-06 2020-06-11 고려대학교 산학협력단 인간 항-antxr 키메라 항원 수용체 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5677274A (en) * 1993-02-12 1997-10-14 The Government Of The United States As Represented By The Secretary Of The Department Of Health And Human Services Anthrax toxin fusion proteins and related methods
DE69941454D1 (de) 1998-07-10 2009-11-05 U S Medical Res Inst Of Infect Impfstoff gegen staphylokokken-vergiftung
GB0016702D0 (en) 2000-07-08 2000-08-23 Secr Defence Brit Expression system

Also Published As

Publication number Publication date
GB0016702D0 (en) 2000-08-23
RU2385348C2 (ru) 2010-03-27
EP1808489A1 (en) 2007-07-18
US7537771B2 (en) 2009-05-26
JP2004502460A (ja) 2004-01-29
RU2270865C2 (ru) 2006-02-27
US20100266639A1 (en) 2010-10-21
US9346860B2 (en) 2016-05-24
AU2007201553B8 (en) 2010-06-03
RU2004134341A (ru) 2006-05-10
EP1808489B1 (en) 2016-03-23
US20130164823A1 (en) 2013-06-27
CN1322134C (zh) 2007-06-20
EP1301606A1 (en) 2003-04-16
US8313928B2 (en) 2012-11-20
JP2012010706A (ja) 2012-01-19
AU2007201553B2 (en) 2010-04-22
WO2002004646A1 (en) 2002-01-17
AU6930501A (en) 2002-01-21
CA2413045C (en) 2016-06-21
CN101012458A (zh) 2007-08-08
CA2413045A1 (en) 2002-01-17
CA2658217A1 (en) 2002-01-17
US20030170263A1 (en) 2003-09-11
AU2007201553A1 (en) 2007-05-03
CN1440459A (zh) 2003-09-03

Similar Documents

Publication Publication Date Title
ZA200210206B (en) Expression system.
MXPA03002410A (es) 4-amino-quinazolinas.
MXPA03005445A (es) Barra colectora 12c para aislar los circuitos integrados seleccionados para una comunicacion rapida de barra colectora 12c.
ZA200100670B (en) Jackpot system.
AU7001701A (en) Liveexception system
ZA200007669B (en) Insert.
EG23262A (en) Delta -pyrrolines.
HK1053470A1 (en) 4-Pyridinyln-acyl-l-phenylalanines.
HK1055426A1 (en) Indoloquinazolinones.
MXPA03001591A (es) Derivados y analogos de 10-aril-11-h-benzo(b) fluorena para uso medicinal.
MXPA03001877A (es) 2-guanidin-4-arilquinazolinas.
MXPA03002668A (es) Guanidinas de sulfonilo.
HK1050018A1 (en) Stable initiator system.
MXPA03005714A (es) Sulfamidotienopirimidinas.
MXPA03002411A (es) 4-amino-quinazolinas.
GB2366895B (en) Ticketless system
MXPA03005494A (es) Benzoilpiridazinas.
HK1061560A1 (en) Triazolo-epothilones.
HK1047167A1 (en) Messaging system.
AU2001289885A8 (en) Air-preparation system
GB0002612D0 (en) C.m.e
GB0007510D0 (en) D.o.t.t.s
HK1031254A1 (en) Tachogragh.
ZA200302241B (en) Triazolo-epothilones.
TJ414B (en) Thermoresistor.